1. COVID-19 vaccination in autoimmune disease (COVAD) survey protocol
- Author
-
Parikshit, Sen, Latika, Gupta, James, B Lilleker, Vishwesh, Aggarwal, Sinan, Kardes, Marcin, Milchert, Tamer, Gheita, Babur, Salim, Tsvetelina, Velikova, Abraham Edgar Gracia-Ramos, Ioannis, Parodis, Albert Selva O'Callaghan, Elena, Nikiphorou, Ai Lyn Tan, Lorenzo, Cavagna, Miguel, A Saavedra, Samuel Katsuyuki Shinjo, Nelly, Ziade, Johannes, Knitza, Masataka, Kuwana, Giovanni, Cagnotto, Arvind, Nune, Oliver, Distler, Hector, Chinoy, Vikas, Aggarwal, Rohit, Aggarwal, COVAD Study Group COVAD Study Group: Bhupen Barman, Yogesh Preet Singh, Rajiv, Ranjan, Avinash, Jain, Sapan, C Pandya, N Malaviya, A, Rakesh Kumar Pilania, Aman, Sharma, M Manesh Manoj, Vikas, Gupta, Chengappa, G Kavadichanda, Pradeepta Sekhar Patro, Sajal, Ajmani, Sanat, Phatak, Rudra Prosad Goswami, Abhra Chandra Chowdhury, Ashish Jacob Mathew, Padnamabha, Shenoy, Ajay, Asranna, Keerthi Talari Bommakanti, Anuj, Shukla, Naveen, R, Döndü Üsküdar Cansu, John, D Pauling, Chris, Wincup, Tulika, Chatterjee, Minchul, Kim, Margherita, Giannini, Nicoletta Del Papa, Gianluca, Sambataro, Atzeni, Fabiola, Marcello, Govoni, Simone, Parisi, Elena Bartoloni Bocci, Gian Domenico Sebastiani, Enrico, Fusaro, Marco, Sebastiani, Luca, Quartuccio, Franceschini, Franco, Pier Paolo Sainaghi, Giovanni, Orsolini, Rossella De Angelis, Maria Giovanna Danielli, Lisa, S Traboco, Suryo Anggoro Kusumo Wibowo, Jorge Rojas Serrano, Ignacio García-De La Torre, Erick Adrian Zamora Tehozol, Jesús, Loarce-Martos, Sergio, Prieto-González, Albert, Gil-Vila, Raquel, Aranega, Ran, Nakashima, Shinji, Sato, Naoki, Kimura, Yuko, Kaneko, Stylianos, Tomaras, Margarita Aleksandrovna Gromova, and Aharonov, Or
- Subjects
medicine.medical_specialty ,COVID-19 Vaccines ,Coronavirus disease 2019 (COVID-19) ,Autoimmune diseases ,Immunology ,Disease ,Observational Research ,Rheumatology ,Internal medicine ,Pandemic ,Humans ,Immunology and Allergy ,Medicine ,Intensive care medicine ,Adverse effect ,Survey ,Autoimmune disease ,business.industry ,Vaccination ,COVAD ,COVID-19 ,medicine.disease ,Increased risk ,Health Care Surveys ,Autoimmune Diseases ,Vaccination Hesitancy ,business - Abstract
The coronavirus disease-2019 (COVID-19) pandemic continues to be a cause of unprecedented global morbidity and mortality. Whilst COVID-19 vaccination has emerged as the only tangible solution to reducing poor clinical outcomes, vaccine hesitancy continues to be an obstacle to achieving high levels of vaccine uptake. This represents particular risk to patients with autoimmune diseases, a group already at increased risk of hospitalization and poor clinical outcomes related to COVID-19 infection. Whilst there is a paucity of long-term safety and efficacy data of COVID-19 vaccination in patients with autoimmune diseases, the current evidence strongly suggests that the benefits of vaccination outweigh the risks of adverse effects and disease flares. Herein, we report the protocol of the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study, an ongoing international collaborative study involving 29 countries and over 110 investigators. Supplementary Information The online version contains supplementary material available at 10.1007/s00296-021-05046-4.
- Published
- 2021